Search for: "Teva Pharmaceuticals"
Results 1361 - 1380
of 1,430
Sort by Relevance
|
Sort by Date
28 Dec 2007, 1:00 am
Highlights this week included: the WTO granting Antigua the right to infringe US copyright up to the tune of $21m, Egypt's proposed new law for royalties on reproductions of ancient monuments and Teva's gutsy launch of Protonix (Pantroprazole). [read post]
27 Dec 2007, 11:00 pm
On Monday, Teva announced that it launched generic Protonix (pantoprazole). [read post]
23 Dec 2007, 8:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at [feeds.feedburner.com]GlobalEvents in Bali heap further pressure on all IP owners: (IAM),Velcro defies generic claim in domain name battle: (OUT-LAW),ICANN forms group to hasten non-English domain names: (IP Justice)WTO members continue debate on geographical indications register: (Intellectual Property Watch),Creative Commons launches CCo and CC programs: (World IP Day),Green IP Strategy - risks… [read post]
8 Dec 2007, 11:00 am
: (IP Think Tank), WIPO - Idris gets paid out to leave early: (IAM), (Patent Prospector), Deutsche Grammophon ditches DRM: (ArsTechnica)PharmaFDA revisits NCE exclusivity for enantiomers: (Arnall Golden & Gregory), Accupril (Quinapril) - Judge finds against Teva and holds Warner-Lambert patent enabled: (IPLaw360), (OrangeBookBlog), Altace / Tritace / Ramace (Ramipril) - King Pharmaceuticals loses CAFC rehearing bid:… [read post]
District Court Upholds Validity of Pfizer's Accupril Patent, Rejecting Teva's Nonenablement Argument
5 Dec 2007, 8:56 pm
" Teva argued that the claims of the '450 patent are extremely broad and the specification provides insufficient guidance to develop the full range of pharmaceutical formulations encompassed by the claims. [read post]
1 Dec 2007, 9:00 am
pharmaceutical companies: (SpicyIP),Great discussion on pharmaceuticals, patents and incentives for innovation: (Generic Pharmaceuticals & IP), (DrugWonks),Adenoscan (Adenosine) - Astellas Pharma, King Pharmaceuticals, and Teva Settle Adenoscan ® Patent Suit: (PatentDocs), Clarinex (Desloratadine) - Schering Corp. adds Anchen Pharmaceuticals Inc. to the long list of companies sued for patent infringement: (IPLaw360), Cosopt… [read post]
29 Nov 2007, 9:32 pm
Earlier this month, Momenta Pharmaceuticals announced that the FDA rejected its ANDA for M-enoxaparin, apparently based on concerns about the generic drug's immunogenicity. [read post]
26 Nov 2007, 9:02 pm
., King Pharmaceuticals, Inc., and Teva Pharmaceutical Industries Ltd. announced that U.S. subsidiaries of Astellas, along with Item Development AB and King have signed settlement agreements with respect to U.S. [read post]
23 Nov 2007, 9:00 am
You can separately subscribe to the IP Thinktank Global week in Review at [duncanbucknell.com]GlobalReputation and privacy in the online social media world: (IPWar's), McAfee typosquatting study results and implications: (IPWar's),Larry Lessig's comments on how creativity is being strangled by the law: (BLOG@IP::JUR)Two interesting papers on Creative Commons: (CreativeCommons)Friction and 'Warfighting': (IP Think Tank),More on the controversy at WIPO over Kamil Idris'… [read post]
21 Nov 2007, 4:08 am
Teva Pharmaceuticals); regarding (1), the court stated that "Canon has established a substantial likelihoodâ€â [read post]
18 Nov 2007, 5:57 pm
Teva Pharmaceuticals USA, Inc. et al. 2:07-cv-05489; filed November 14, 2007 in the... [read post]
10 Nov 2007, 9:26 pm
Teva and Upsher-Smith recently submitted new comments to FDA regarding acarbose 180-day exclusivity (see FDA Law Blog). [read post]
6 Nov 2007, 9:57 pm
Reddy's; Purepac; Roxane; Sandoz; and Teva (see this web page). [read post]
1 Nov 2007, 4:18 pm
Patent No. 6,610,327, claiming pharmaceutical formulations of moxifloxacin. [read post]
18 Oct 2007, 11:00 pm
Quite right, said the CFI, dismissing Intervideo's appeal - CFI decision in Case T-105/06 Intervideo v OHIM, (IPKat)EPO adds EPC post-grant data to PRS database (EPO), EU Patent Jurisdiction: Details of New Proposals From Portuguese EU Presidency (Blog@IPR::JUR), (IAM), Teva invalidates acid metabolite patents for terfenedine, (Teva Pharmaceutical Industries Ltd and another v Merrell Pharmaceuticals Inc, Aventis and Sepracor [2007] EWHC 2276 (Ch) ), (IPKat),… [read post]
17 Oct 2007, 10:00 pm
I have just found out from the Generic Pharmaceuticals and IP blog that Teva has now sued 16 companies in relation to its Carvedilol process patents.The 16 defendants are: Zentiva; Mylan; Taro Pharmaceuticals; Lupin; Moehs Iberica; Urquima; Orchid; Wanbury;Z hejiang Huahai; USV Ltd.; Cadila; Ranbaxy; Dr. [read post]
16 Oct 2007, 2:19 am
Court of Appeal (Civil Division) Austin & Anor v Commissioner of Police of the Metropolis [2007] EWCA Civ 989 (15 October 2007) L’Oreal SA & Ors v Bellure NV & Ors [2007] EWCA Civ 968 (10 October 2007) Holmes-Moorhouse v London Borough of Richmond-Upon-Thames [2007] EWCA Civ 970 (10 October 2007) Procter & Gamble Company v Reckitt Benckiser (UK) Ltd [2007] EWCA Civ 936 (10 October 2007) Charman v Orion Group Publishing Group Ltd & Ors [2007] EWCA… [read post]
14 Oct 2007, 7:17 pm
Teva Pharmaceutical Industries Ltd. et al. v. [read post]
12 Oct 2007, 10:03 am
" Claim 1 of the '450 patent is directed to a pharmaceutical composition comprising an ACE inhibitor; "an alkali or alkaline earth metal carbonate"; and a saccharide. [read post]
1 Oct 2007, 1:45 am
Reddy's Laboratories and Teva Pharmaceutical Industries had argued that Lilly's patent was no longer valid because discovery of Zyprexa's molecular structure was covered by a previous Lilly patent.Separately:Several states are suing Lilly, claiming it marketed Zyprexa for off-label uses, including treatment of dementia, depression and autism, without warning about its risks.Alsohttp://ipbiz.blogspot.com/2006/12/lillys-zyprexa-patent-upheld-at-cafc.html [read post]
